MARKET

CDTX

CDTX

Cidara Theraptcs
NASDAQ
18.63
-0.52
-2.72%
After Hours: 18.63 0 0.00% 16:05 05/09 EDT
OPEN
20.97
PREV CLOSE
19.15
HIGH
20.97
LOW
18.51
VOLUME
61.61K
TURNOVER
--
52 WEEK HIGH
28.42
52 WEEK LOW
10.14
MARKET CAP
233.74M
P/E (TTM)
-0.6966
1D
5D
1M
3M
1Y
5Y
1D
Cidara Therapeutics’ CD388 Progress and Challenges Highlighted in Earnings Call
TipRanks · 11h ago
Cidara Therapeutics Is Maintained at Buy by Guggenheim
Dow Jones · 20h ago
Guggenheim Maintains Buy on Cidara Therapeutics, Raises Price Target to $35
Benzinga · 20h ago
Cidara Therapeutics Price Target Raised to $47.00/Share From $46.00 by JMP Securities
Dow Jones · 22h ago
Cidara Therapeutics Is Maintained at Market Outperform by JMP Securities
Dow Jones · 22h ago
JMP Securities Maintains Market Outperform on Cidara Therapeutics, Raises Price Target to $47
Benzinga · 22h ago
Cidara Therapeutics price target raised to $35 from $33 at Guggenheim
TipRanks · 1d ago
CIDARA THERAPEUTICS INC <CDTX.O>: GUGGENHEIM RAISES TARGET PRICE TO $35 FROM $33
Reuters · 1d ago
More
About CDTX
More
Cidara Therapeutics, Inc. is a biotechnology company. The Company is developing targeted immunotherapies designed for patients facing serious diseases. The Company’s portfolio comprises various treatment and prevention paradigms, including drug-Fc conjugate (DFC) from its Cloudbreak platform targeting oncologic, viral and autoimmune diseases. The Company is focused on advancing Cloudbreak development programs, including its lead oncology candidate, CBO421, as well as advancing other pipeline assets. CBO421 is a development candidate targeting CD73 for the treatment of solid tumors. Its advanced DFC program is CD388, a highly potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase I and Phase IIa clinical trials. Its additional programs target multiple autoimmune indications.
Recently
Symbol
Price
%Change

Webull offers Cidara Therapeutics Inc stock information, including NASDAQ: CDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDTX stock methods without spending real money on the virtual paper trading platform.